Rosetta: Project News Jun 18, 2011

Journal post from David BakerThis week's issue of Nature magazine has an exciting article (http://www.nature.com/nature/journal...ture10154.html) describing work we are doing with collaborators using Rosetta to design a new class of inhibitors of amyloid fibril formation. Amyloid fibrils have been implicated in Alzheimer's and many other diseases. The designed peptides are not suitable for use as actual therapeutics in their present form, but hopefully will help lead the way to effective drugs.

More...